Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products : workshop summary /
Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors associated with the chemistry of a drug, and limitations in the research and clinical trial process i...
| Clasificación: | Libro Electrónico | 
|---|---|
| Autor principal: | |
| Autor Corporativo: | |
| Otros Autores: | , | 
| Formato: | Electrónico Congresos, conferencias eBook | 
| Idioma: | Inglés | 
| Publicado: | Washington, D.C. :
        
      National Academies Press,    
    
      [2014] | 
| Temas: | |
| Acceso en línea: | Texto completo | 
                Tabla de Contenidos: 
            
                  - Introduction
- Identifying and characterizing uncertainty
- The regulators' challenge
- Basic methodologies and applications for understanding and evaluating uncertainty
- Communicating uncertainty
- Final reflections on ways to characterize and communicate uncertainty.
 


